Skip to main content
Top
Published in: Acta Diabetologica 1/2012

01-12-2012 | Original Article

Decreased beta cell function and insulin sensitivity contributed to increasing fasting glucose in Chinese

Authors: Yan Bi, Dalong Zhu, Yali Jing, Yun Hu, Wenhuan Feng, Shanmei Shen, Guoyu Tong, Xujun Shen, Tingting Yu, Dan Song, Donghui Yang

Published in: Acta Diabetologica | Special Issue 1/2012

Login to get access

Abstract

To evaluate the role of insulin resistance and beta cell function to increasing fasting plasma glucose (FPG), 1,272 Chinese subjects (18–80 years of age) were divided into normal glucose tolerance (NGT), impaired fasting glucose (IFG), impaired glucose tolerance (IGT), combined glucose intolerance (CGI), and type 2 diabetes mellitus (T2DM) according to oral glucose tolerance test. Insulin sensitivity was measured by Matsuda index (ISIM) and homeostasis model assessment of insulin resistance (1/HOMA-IR); β-cell function adjusted by insulin sensitivity was assessed from disposition index (DI) at basal DI0 (homeostasis model assessment of β-cell function (HOMA-B) × [1/HOMA-IR]), early-phase DI30 (the ratio of total insulin AUC and total glucose AUC during 0–30 min of the OGTT (InsAUC30/GluAUC30) × ISIM) and total DI120 (the ratio of total insulin AUC and total glucose AUC during 0–120 min of the OGTT (InsAUC120/GluAUC120) × ISIM). Compared with NGT, in IFG, ISIM (−23%), DI0 (−38%), DI30 (−30%), and DI120 (−31%) were decreased significantly. As the FPG increased across categories classified by FPG levels from NGT → IFG → T2DM with 2 h PG < 7.8 mmol/l, ISIM, DI0, DI30 and DI120 showed decline beginning from normal range of FPG, compared with the reference category of FPG < 4.0 mmol/l. Correlation analysis showed that ISIM and DI were correlated inversely with FPG concentration (r = −0.242 for ISIM, r = −0.933 for DI0, r = −0.806 for DI30, r = −0.817 for DI120; P < 0.001). Both the impairment of beta cell function and insulin sensitivity started at the low point of FPG within the normoglycemic range and contributed to the deterioration of fasting glucose.
Literature
1.
go back to reference Cnop M, Vidal J, Hull RL, Utzschneider KM, Carr DB, Schraw T, Scherer PE, Boyko EJ, Fujimoto WY, Kahn SE (2007) Progressive loss of β-Cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 30:677–682PubMedCrossRef Cnop M, Vidal J, Hull RL, Utzschneider KM, Carr DB, Schraw T, Scherer PE, Boyko EJ, Fujimoto WY, Kahn SE (2007) Progressive loss of β-Cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 30:677–682PubMedCrossRef
2.
go back to reference Fernández-Castañer M, Biarnés J, Camps I, Ripollés J, Gómez N, Soler J (1996) Beta-cell dysfunction in first-degree relatives of patients with non-insulin dependent diabetes mellitus. Diabet Med 13:953–959PubMedCrossRef Fernández-Castañer M, Biarnés J, Camps I, Ripollés J, Gómez N, Soler J (1996) Beta-cell dysfunction in first-degree relatives of patients with non-insulin dependent diabetes mellitus. Diabet Med 13:953–959PubMedCrossRef
3.
go back to reference Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE, GENNID American Diabetes Association Study Group (2002) Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 51:2170–2178PubMedCrossRef Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE, GENNID American Diabetes Association Study Group (2002) Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 51:2170–2178PubMedCrossRef
4.
go back to reference Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J (1995) Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 273:1855–1861PubMedCrossRef Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J (1995) Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 273:1855–1861PubMedCrossRef
5.
go back to reference Chen KW, Boyko EJ, Bergstrom RW, Leonetti DL, Newell-Morris L, Wahl PW, Fujimoto WY (1995) Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM: 5-year follow-up of initially nondiabetic Japanese-American men. Diabetes Care 18:747–753PubMedCrossRef Chen KW, Boyko EJ, Bergstrom RW, Leonetti DL, Newell-Morris L, Wahl PW, Fujimoto WY (1995) Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM: 5-year follow-up of initially nondiabetic Japanese-American men. Diabetes Care 18:747–753PubMedCrossRef
6.
go back to reference Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widén E, Schalin C, Groop L (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337–343PubMedCrossRef Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widén E, Schalin C, Groop L (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337–343PubMedCrossRef
7.
go back to reference Haffner SM, Miettinen H, Stern MP (1997) Are risk factors for conversion to NIDDM similar in high and low risk populations? Diabetologia 40:62–66PubMedCrossRef Haffner SM, Miettinen H, Stern MP (1997) Are risk factors for conversion to NIDDM similar in high and low risk populations? Diabetologia 40:62–66PubMedCrossRef
8.
go back to reference Abdul-Ghani MA, Sabbah M, Kher J, Minuchin O, Vardi P, Raz I (2006) Different contributions of insulin resistance and beta-cell dysfunction in overweight Israeli Arabs with IFG and IGT. Diabetes Metab Res Rev 22:126–130PubMedCrossRef Abdul-Ghani MA, Sabbah M, Kher J, Minuchin O, Vardi P, Raz I (2006) Different contributions of insulin resistance and beta-cell dysfunction in overweight Israeli Arabs with IFG and IGT. Diabetes Metab Res Rev 22:126–130PubMedCrossRef
9.
go back to reference Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY (1990) Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39:104–111PubMedCrossRef Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY (1990) Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39:104–111PubMedCrossRef
10.
go back to reference Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, Matsuura T, Suzuki H, Kurose T, Yamada Y, Seino Y (2004) Insulin secretion and insulin sensitivity at different stages of glucose tolerance: A cross-sectional study of Japanese type 2 diabetes. Metabolism 53:831–835PubMedCrossRef Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, Matsuura T, Suzuki H, Kurose T, Yamada Y, Seino Y (2004) Insulin secretion and insulin sensitivity at different stages of glucose tolerance: A cross-sectional study of Japanese type 2 diabetes. Metabolism 53:831–835PubMedCrossRef
11.
go back to reference Haffner SM, Miettinen H, Gaskill SP, Stern MP (1995) Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44:1386–1391PubMedCrossRef Haffner SM, Miettinen H, Gaskill SP, Stern MP (1995) Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44:1386–1391PubMedCrossRef
12.
go back to reference Pontiroli AE, Monti LD, Costa S, Sandoli PE, Pizzini A, Solerte SB, Mantovani E, Piatti PM (2000) In middle-aged siblings of patients with type 2 diabetes mellitus normal glucose tolerance is associated with insulin resistance and with increased insulin secretion: the SPIDER study. Eur J Endocrinol 143:681–686PubMedCrossRef Pontiroli AE, Monti LD, Costa S, Sandoli PE, Pizzini A, Solerte SB, Mantovani E, Piatti PM (2000) In middle-aged siblings of patients with type 2 diabetes mellitus normal glucose tolerance is associated with insulin resistance and with increased insulin secretion: the SPIDER study. Eur J Endocrinol 143:681–686PubMedCrossRef
13.
go back to reference Stancáková A, Javorský M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M (2009) Changes in Insulin Sensitivity and Insulin Release in Relation to Glycemia and Glucose Tolerance in 6, 414 Finnish Men. Diabetes 58:1212–1221PubMedCrossRef Stancáková A, Javorský M, Kuulasmaa T, Haffner SM, Kuusisto J, Laakso M (2009) Changes in Insulin Sensitivity and Insulin Release in Relation to Glycemia and Glucose Tolerance in 6, 414 Finnish Men. Diabetes 58:1212–1221PubMedCrossRef
14.
go back to reference Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215–2221PubMedCrossRef Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215–2221PubMedCrossRef
15.
go back to reference Pang C, Bao YQ, Wang C, Lu JX, Jia WP, Xiang KS (2008) Relationship between the level of fasting plasma glucose and beta cell functions in Chinese with or without diabetes. Chin Med J 121:2119–2123PubMed Pang C, Bao YQ, Wang C, Lu JX, Jia WP, Xiang KS (2008) Relationship between the level of fasting plasma glucose and beta cell functions in Chinese with or without diabetes. Chin Med J 121:2119–2123PubMed
16.
go back to reference Qian L, Xu L, Wang X, Fu X, Gu Y, Lin F, Peng Y, Li G, Luo M (2009) Early insulin secretion failure leads to diabetes in Chinese subjects with impaired glucose regulation. Diabetes Metab Res Rev 25:144–149PubMedCrossRef Qian L, Xu L, Wang X, Fu X, Gu Y, Lin F, Peng Y, Li G, Luo M (2009) Early insulin secretion failure leads to diabetes in Chinese subjects with impaired glucose regulation. Diabetes Metab Res Rev 25:144–149PubMedCrossRef
17.
go back to reference The Expert Committee on the Diagnosis, Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197 The Expert Committee on the Diagnosis, Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
18.
go back to reference The Expert Committee on the Diagnosis, Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167CrossRef The Expert Committee on the Diagnosis, Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167CrossRef
20.
go back to reference Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedCrossRef Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedCrossRef
21.
go back to reference Stumvoll M, Van Haeften T, Fritsche A, Gerich J (2001) Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24:796–797PubMedCrossRef Stumvoll M, Van Haeften T, Fritsche A, Gerich J (2001) Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24:796–797PubMedCrossRef
22.
go back to reference Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 55:1430–1435PubMedCrossRef Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 55:1430–1435PubMedCrossRef
23.
go back to reference Cobelli C, Toffolo GM, Man CD, Campioni M, Denti P, Caumo A, Butler P, Rizza R (2007) Assessment of β-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 293:1–15CrossRef Cobelli C, Toffolo GM, Man CD, Campioni M, Denti P, Caumo A, Butler P, Rizza R (2007) Assessment of β-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 293:1–15CrossRef
24.
go back to reference Yang WY, Lu JM, Weng JP, Jia WP, Ji LN, Xiao JZ, Shan ZY, Liu J, Tian HM, Ji QH, Zhu DL, Ge JP, Lin LX, Chen L, Guo XH, Zhao ZG, Li Q, Zhou ZG, Shan GL, He J, for the China National Diabetes, Metabolic disorders study (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101PubMedCrossRef Yang WY, Lu JM, Weng JP, Jia WP, Ji LN, Xiao JZ, Shan ZY, Liu J, Tian HM, Ji QH, Zhu DL, Ge JP, Lin LX, Chen L, Guo XH, Zhao ZG, Li Q, Zhou ZG, Shan GL, He J, for the China National Diabetes, Metabolic disorders study (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101PubMedCrossRef
25.
go back to reference Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, Mo J, Whelton PK, He J, InterASIA Collaborative Group (2003) Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 46:1190–1198PubMedCrossRef Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, Mo J, Whelton PK, He J, InterASIA Collaborative Group (2003) Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 46:1190–1198PubMedCrossRef
26.
go back to reference Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 3:57–63CrossRef Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 3:57–63CrossRef
27.
go back to reference han JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301:2129–2140CrossRef han JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301:2129–2140CrossRef
28.
go back to reference Torrens J, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M, Lasser N, Weiss G (2004) Ethnic differences in insulin sensitivity and β-cell function in premenopausal or early perimenopausal women without diabetes. The study of women’s health across the nation (SWAN). Diabetes Care 27:354–361PubMedCrossRef Torrens J, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M, Lasser N, Weiss G (2004) Ethnic differences in insulin sensitivity and β-cell function in premenopausal or early perimenopausal women without diabetes. The study of women’s health across the nation (SWAN). Diabetes Care 27:354–361PubMedCrossRef
29.
go back to reference Davies MJ, Raymond NT, Day JL, Hales CN, Burden AC (2000) Impaired glucose tolerance and fasting hyperglycemia have different characteristics. Diabet Med 17:433–440PubMedCrossRef Davies MJ, Raymond NT, Day JL, Hales CN, Burden AC (2000) Impaired glucose tolerance and fasting hyperglycemia have different characteristics. Diabet Med 17:433–440PubMedCrossRef
30.
go back to reference Kanauchi M, Nakajima M, Saito Y, Kanauchi K (2003) Pancreatic beta-cell function and insulin sensitivity in Japanese subjects with impaired glucose tolerance and newly diagnosed type 2 Diabetes Mellitus. Metabolism 52:476–481PubMedCrossRef Kanauchi M, Nakajima M, Saito Y, Kanauchi K (2003) Pancreatic beta-cell function and insulin sensitivity in Japanese subjects with impaired glucose tolerance and newly diagnosed type 2 Diabetes Mellitus. Metabolism 52:476–481PubMedCrossRef
31.
go back to reference Hong J, Gui MH, Gu WQ, Zhang YF, Xu M, Chi ZN, Zhang Y, Li XY, Wang WQ, Ning G (2008) Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose. Diabet Med 25:73–79PubMed Hong J, Gui MH, Gu WQ, Zhang YF, Xu M, Chi ZN, Zhang Y, Li XY, Wang WQ, Ning G (2008) Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose. Diabet Med 25:73–79PubMed
Metadata
Title
Decreased beta cell function and insulin sensitivity contributed to increasing fasting glucose in Chinese
Authors
Yan Bi
Dalong Zhu
Yali Jing
Yun Hu
Wenhuan Feng
Shanmei Shen
Guoyu Tong
Xujun Shen
Tingting Yu
Dan Song
Donghui Yang
Publication date
01-12-2012
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue Special Issue 1/2012
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-010-0194-4

Other articles of this Special Issue 1/2012

Acta Diabetologica 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine